Home » Genzyme’s Diagnostics Unit Acquired for $265 Million
Genzyme’s Diagnostics Unit Acquired for $265 Million
While rumors spread over companies eyeing a buyout of Genzyme Corp. as a whole, the Cambridge biotech has indeed announced a divestiture — of its diagnostics business.
Mass High Tech
Mass High Tech
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May